Do we know bad science when we see it?

Journal of Thoracic and Cardiovascular Surgery

Volumn 150, Issue 3, 2015, Pages 472-473

  Jones, David R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG LOBECTOMY; MULTICENTER STUDY (TOPIC); NON SMALL CELL LUNG CANCER; NOTE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC PROCEDURE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; MALE; RADIOSURGERY; TEMPORAL LOBECTOMY; TUMOR RECURRENCE;

ANTERIOR TEMPORAL LOBECTOMY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY;

EID: 84940453518     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2015.07.032     Document Type: Editorial

References (3)

1. G. Galilei The Assayer trans. D. Stillman, Discoveries and Opinions of Galileo 1957 Doubleday & Co New York 237 238
2. B.F. Meyers, V. Puri, S.R. Broderick, P. Samson, K. Keogan, and T.D. Crabtree Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: post hoc analysis dressed up as level I evidence? J Thorac Cardiovasc Surg 150 2015 468 471
3. J.Y. Chang, S. Senan, M.A. Paul, R.J. Mehran, A.V. Louie, P. Balter, and et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: a pooed analysis of two randomized trials Lancet Oncol 16 2015 630 637